Buenos Aires, Argentina
October 16, 2013
University of Buenos Aires, School of Law
A body of emerging evidence suggests that while not essential to life, flavonoids confer a range of effects that may support health and improve quality of life. In light of the consistent scientific and consumer interest in the role of these bioactive components, there is a need to consider a framework that could be applied to evaluate these components and enable evidence-based recommendations regarding their intake at levels that are safe, effective and benefit health. This session covered factors for consideration in making evidence-based dietary guidance possible, including:
- An overview of a recent guidance document providing recommendations for designing, implementing and reporting clinical studies involving flavonoids.
- A look at the type and level of evidence needed to support a public health recommendation, with particular emphasis on the link between flavonoids and vessel function and blood pressure.
- The limitations in applying the current Dietary Reference Intake development process in the U.S. and elsewhere to flavonoids.
- Elements that need to be considered in developing a path forward for dietary guidance involving flavonoids.
This session was supported by the ILSI North America Technical Committee on Bioactives: Flavonoids, Polyphenols, and Carotenoids.